Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial
2023 · The Lancet · 96 citations
https://doi.org/10.1016/s0140-6736(23)02179-7